1. PEDOT-AuNPs-based impedimetric immunosensor for the detection of SARS-CoV-2 antibodies
- Author
-
Ana Luiza Lorenzen, Ariane Moraes dos Santos, Luâni Poll dos Santos, Luciano da Silva Pinto, Fabricio Rochedo Conceição, and Franciele Wolfart
- Subjects
Impedimetric biosensor ,SARS-CoV-2 ,General Chemical Engineering ,Electrochemistry ,COVID-19 ,Gold nanoparticles ,Impedance spectroscopy ,Article ,PEDOT - Abstract
Electrochemical sensors and biosensors are useful techniques for fast, inexpensive, sensitive, and easy detection of innumerous specimen. In face of COVID-19 pandemic, it became evident the necessity of a rapid and accurate diagnostic test, so the impedimetric immunosensor approach can be a good alternative to replace the conventional tests due to the specific antibody-antigen binding interaction and the fast response in comparison to traditional methods. In this work, a modified electrode with electrosynthesized PEDOT and gold nanoparticles followed by the immobilization of truncated nucleoprotein (N aa160–406aa) was used for a fast and reliable detection of antibodies against COVID-19 in human serum sample. The method consists in analyzing the charge-transfer resistance (RCT) variation before and after the modified electrode comes into contact with the positive and negative serum sample for COVID-19, using [Fe(CN)6]3-/4− as a probe. The results show a linear and selective response for serum samples diluted in a range of 2.5 × 103 to 20 × 103. Also, the electrode material was fully characterized by Raman spectroscopy, transmission electron microscopy and scanning electron microscopy coupled with EDS, indicating that the gold nanoparticles were well distributed around the polymer matrix and the presence of the biological sample was confirmed by EDS analysis. EIS measurements allowed to differentiate the negative and positive samples by the difference in the RCT magnitude, proving that the material developed here has potential properties to be applied in impedimetric immunosensors for the detection of SARS-CoV-2 antibodies in about 30 min., Graphical abstract Image, graphical abstract
- Published
- 2021